165 related articles for article (PubMed ID: 37246762)
1. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.
Bresciani L; Salvalaggio A; Vegezzi E; Visentin A; Fortuna A; Anglani M; Cacciavillani M; Masciocchi S; Scaranzin S; Carecchio M; Martinuzzi A; Gastaldi M; Briani C
J Peripher Nerv Syst; 2023 Sep; 28(3):522-527. PubMed ID: 37246762
[TBL] [Abstract][Full Text] [Related]
2. Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
Afanasiev V; Tsouni P; Kuntzer T; Cairoli A; Delmont E; Vallat JM; Devaux J; Théaudin M
J Peripher Nerv Syst; 2024 Mar; 29(1):116-119. PubMed ID: 38123899
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Fehmi J; Lleixà C; Martín-Aguilar L; Devaux J; Höftberger R; Delmont E; Doppler K; Sommer C; Radunovic A; Carvajal A; Smyth S; Williams L; Mazanec R; Potočková V; Hinds N; Cassereau J; Viala K; Lefilliatre M; Nicolas G; Foley P; Leypoldt F; Keddie S; Lunn MP; Zimprich F; Nunkoo VS; Löscher WN; Martínez-Martínez L; Díaz-Manera J; Rojas-Garcia R; Illa I; Rinaldi S; Querol L
Brain; 2021 May; 144(4):1183-1196. PubMed ID: 33880507
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
6. Effect of monovalency on anti-contactin-1 IgG4.
Taieb G; Jentzer A; Vegezzi E; Lleixà C; Illa I; Querol L; Devaux JJ
Front Immunol; 2023; 14():1021513. PubMed ID: 36999029
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
Broers MC; Wieske L; Erdag E; Gürlek C; Bunschoten C; van Doorn PA; Eftimov F; Kuitwaard K; de Vries JM; de Wit MY; Nagtzaam MM; Franken SC; Zhu L; Paunovic M; de Wit M; Schreurs MW; Lleixà C; Martín-Aguilar L; Pascual-Goñi E; Querol L; Jacobs BC; Huizinga R; Titulaer MJ
J Neurol Neurosurg Psychiatry; 2023 Dec; 95(1):52-60. PubMed ID: 37879898
[TBL] [Abstract][Full Text] [Related]
9. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
10. Case report: Immunoadsorption therapy for anti-caspr1 antibody-associated nodopathy.
Liu L; Chen J; Zhang Y; Wu J; Hu J; Lin Z
Front Immunol; 2022; 13():986018. PubMed ID: 36211443
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies.
Briani C; Visentin A
Neurotherapeutics; 2022 Apr; 19(3):874-884. PubMed ID: 35349079
[TBL] [Abstract][Full Text] [Related]
12. Growing Spectrum of Autoimmune Nodopathies.
Gupta P; Mirman I; Shahar S; Dubey D
Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
Delmont E; Brodovitch A; Kouton L; Allou T; Beltran S; Brisset M; Camdessanché JP; Cauquil C; Cirion J; Dubard T; Echaniz-Laguna A; Grapperon AM; Jauffret J; Juntas-Morales R; Kremer LD; Kuntzer T; Labeyrie C; Lanfranco L; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Nicolas G; Noury JB; Perie M; Rajabally YA; Remiche G; Rouaud V; Tard C; Salort-Campana E; Verschueren A; Viala K; Wang A; Attarian S; Boucraut J
J Neurol; 2020 Dec; 267(12):3664-3672. PubMed ID: 32676765
[TBL] [Abstract][Full Text] [Related]
14. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
15. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
16. Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies.
Appeltshauser L; Messinger J; Starz K; Heinrich D; Brunder AM; Stengel H; Fiebig B; Ayzenberg I; Birklein F; Dresel C; Dorst J; Dvorak F; Grimm A; Joerk A; Leypoldt F; Mäurer M; Merl P; Michels S; Pitarokoili K; Rosenfeldt M; Sperfeld AD; Weihrauch M; Welte GS; Sommer C; Doppler K
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35314491
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E
Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
[TBL] [Abstract][Full Text] [Related]
18. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
[TBL] [Abstract][Full Text] [Related]
19. Aggressive Acquired Demyelinating Neuropathy Caused by NF-155: Initially Treatment-Resistant.
Jamall S; Baker N; Peterson G; Tsao B; Rosenfeld J
J Clin Neuromuscul Dis; 2023 Dec; 25(2):59-62. PubMed ID: 37962191
[TBL] [Abstract][Full Text] [Related]
20. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]